Someday embryos will not be needed, says leading researcher
MIT scientist implies that they are basically benchmarks
There is more spin
in discussions of embryonic stem cells than in the average gyroscope. Even
eminent scientists tend to glide over the disadvantages of their preferred cell
type. But quite consistently throughout years of debate, four uses for these
cells have been mentioned: curing dread diseases, testing drugs, doing genetic
research, and benchmarking performance. What no scientist in favour of using
them has ever mentioned is that someday they would no longer be needed.
Until now. Dr
Rudolph Jaenisch, a leading and often-quoted researcher at the Massachusetts
Institute of Technology, told the New York Times that scientists currently need
embryonic stem cells to benchmark the performance of adult stem cells and induced
pluripotent stem cells. But then he admitted that this would not be
the case for ever. “Things are very much in flux,” he said. “We will probably
need human embryonic stem cells for a while. And then we probably will not need
them anymore.” ~ New York
Times, Aug 25
Michael Cook
stem cells
- How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
- House of Lords debates assisted suicide—again - October 28, 2021
- Spanish government tries to restrict conscientious objection - October 28, 2021
More Stories
Mortality rates for American kids are rising for the first time in 50 years
US President Joe Biden is so concerned about the future of American children that he inserted a mandate for affordable...
Will Pope Francis be composted?
Will Pope Francis be composted instead of buried in St Peter’s Basilica in Rome with his predecessors? It’s unlikely. But...
The virtues and the vices of the outrageous
A Norwegian bioethicist, Anna Smajdor, recently set out a case for “Whole Body Gestational Donation” – using the wombs of...
More than 200 people have been treated with experimental CRISPR therapies
Scientists believe that CRISPR gene editing technologies will transform medicine. But how many people have been treated so far? According...
Asia-Pacific IVF market could reach US$46 billion by 2031
According to a market survey by Allied Market Research, IVF is booming in the Asia-Pacific region. The market size was...
Third global summit on human genome editing: Moving on after the He experiment
The much anticipated Third International Summit on Human Genome Editing was held in London earlier this month to explore the...